BHVN Q2 2021 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena

BHVNBiohaven Ltd.

$1B

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$93M+858.3% YoY

Gross Profit

$76M81.3% margin

Operating Income

-$172M-185.0% margin

Net Income

-$211M-226.6% margin

EPS (Diluted)

$-3.23

QoQ Revenue Growth

+112.1%

Cash Flow

Operating Cash Flow

-$35M

Free Cash Flow

-$35M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$846M

Total Liabilities

$1.2B

Stockholders' Equity

-$454M

Cash & Equivalents

$306M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$93M	$10M	+858.3%
Gross Profit	$76M	$7M	+1038.5%
Operating Income	-$172M	-$161M	-7.0%
Net Income	-$211M	-$181M	-16.4%